首页|槲皮苷通过调控转化生长因子-β/smads信号通路抑制结肠癌细胞迁移与侵袭

槲皮苷通过调控转化生长因子-β/smads信号通路抑制结肠癌细胞迁移与侵袭

扫码查看
目的 探讨槲皮苷通过调控转化生长因子-β1(TGF-β1)/smads信号通路抑制结肠癌细胞迁移与侵袭。方法 HCT116结肠癌细胞分为对照组、槲皮苷低、中、高剂量组,分别使用0、5、10、20 μmol/L槲皮苷处理48 h,噻唑蓝(MTT)实验检测细胞活力,迁移实验检测细胞迁移能力,Transwell实验检测细胞侵袭能力,蛋白质印迹法(Western blot)检测基质金属蛋白酶-9(MMP-9)、基质金属蛋白酶抑制剂-1(TIMP-1)、波形蛋白(Vimentin)、E-钙黏蛋白(E-cadherin)、TGF-β1、p-Smad2及p-Samd3蛋白表达,采用F检验分析组间差异。结果 槲皮苷低、中、高剂量组细胞活力(0。48±0。01、0。41±0。01、0。34±0。01 比 0。54±0。02,F=26。354,P<0。05)、细胞迁移数目[(117。62±3。49)、(43。36±2。53)、(35。56±1。32)个 比(176。48±9。35)个,F=35。624,P<0。05]、细胞侵袭数目[(86。31±3。83)、(41。28±2。26)、(30。41±1。26)个比(182。43±9。21)个,F=36。520,P<0。05]、MMP-9(0。98±0。05、0。46±0。02、0。32±0。01 比 0。35±0。01,F=26。546,P<0。05)、Vimentin(0。53±0。03、0。41±0。03、0。20±0。01 比 0。08±0。00、F=27。649,P<0。05)、TGF-β1(0。82±0。05、0。74±0。04、0。70±0。04 比 0。35±0。01,F=30。325,P<0。05)、p-Smad2(1。78±0。09、1。56±0。10、0。84±0。05 比 0。41±0。03,F=33。654,P<0。05)及 p-Smad3 蛋白表达量(1。94±0。12、0。87±0。07、0。56±0。04比0。28±0。01,F=35。674,P<0。05)低于对照组,槲皮苷低、中、高剂量组中TIMP-1(0。21±0。01、0。31±0。02、0。46±0。03 比 0。64±0。04,F=28。413,P<0。05)、E-cadherin 蛋白表达量(0。09±0。00、0。22±0。01、0。43±0。02 比 0。89±0。07,F=28。561,P<0。05)高于对照组。结论 槲皮苷能抑制HCT116细胞迁移及侵袭,可能与抑制TGF-β1/smad2/3信号通路有关。
Effect of quercitrin on migration and invasion of colon cancer by transforming growth factor beta/samds signal pathway
Objective To explore the effect of quercitrin on migration and invasion of colon cancer by modulating transforming growth factor beta1(TGF-β1)/samds signal pathway.Methods HCT116 co-lon cancer cells were divided into control group,low-,medium-,and high-dose quercetin groups,and trea-ted with 0,5,10,and 20 µmol/L quercetin for 48 h,respectively.Cell viability was measured by methyl thiazolyl tetrazolium(MTT)assay.Cell migration ability was detected by migration test.Cell invasion abil-ity was detected by Transwell test.The expression of matrix metalloproteinase-9(MMP-9),tissue inhibitor of metalloproteinase-1(TIMP-1),Vimentin,E-cadherin,TGF-β1,p-Smad2 and p-Smad3 was detected by Western blotting.Inter group differences were analyzed by F-test.Results Cell viability(0.48±0.01,0.41±0.01,0.34±0.01 vs.0.54±0.02,F=26.354,P<0.05),the number of migrating cells[(117.62±3.49),(43.36±2.53),(35.56±1.32)vs.(176.48±9.35)F=35.624,P<0.05],the number of invasive cells[(86.31±3.83),(41.28±2.26),(30.41±1.26)vs.(182.43±9.21),F=36.520,P<0.05],the expression of MMP-9(0.98±0.05,0.46±0.02,0.32±0.01 vs.0.35±0.01,F=26.546,P<0.05),Vimentin(0.53±0.03,0.41±0.03,0.20±0.01 vs.0.08±0.00,F=27.649,P<0.05),TGF-β1(0.82±0.05,0.74±0.04,0.70±0.04 vs.0.35±0.01,F=30.325,P<0.05),p-Smad2(1.78±0.09,1.56±0.10,0.84±0.05vs.0.41±0.03,F=33.654,P<0.05)and p-Smad3(1.94±0.12,0.87±0.07,0.56±0.04 vs.0.28±0.01,F=35.674,P<0.05)protein in low-,medium-,and high-dose quercetin groups were significantly reduced as compared with those in con-trol group.The expression of TIMP-1(0.21±0.01,0.31±0.02,0.46±0.03 vs.0.64±0.04,F=28.413,P<0.05),E-cadherin(0.09±0.00,0.22±0.01,0.43±0.02 vs.0.89±0.07,F=28.561,P<0.05)protein in low-,medium-,and high-dose quercetin groups was higher than that in control group.Conclusion Quercitrin could inhibit migration and invasion of HCT116 colon cancer cells probably by suppressing the TGF-β1/smad2/3 signal pathway.

QuercitrinColon cancerMigrationInvasionTransforming growth factor beta1/samds signal pathway

李丹、张宏博、郝旭雯、徐新生

展开 >

天津医科大学总医院中医科,天津 300052

天津市南开医院肿瘤科,天津 300102

天津市南开医院消化科,天津 300102

天津市南开医院外四科,天津 300102

展开 >

槲皮苷 结肠癌 迁移 侵袭 转化生长因子-β1/smads信号通路

国家自然科学基金国家自然科学基金国家自然科学基金

820742138227425382204988

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(7)
  • 6